ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 295

Brain Biopsy Diagnosis in Magnetic Resonance Imaging Negative Childhood Primary Angiitis of the Central Nervous System

Senq-J Lee1, Cynthia Hawkins2, Suzanne Laughlin3, Shehla Sheikh4 and Susanne M. Benseler4, 1Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 3Diagnostic Imaging, The Hospital for Sick Children, Toronto, ON, Canada, 4Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), pediatric rheumatology and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Primary CNS vasculitis in childhood (cPACNS) is a devastating inflammatory brain disease mandating rapid and accurate diagnostic evaluation, in order to optimize neurologic outcomes.  Traditional investigations including inflammatory markers are often abnormal, but not specific.  Neuroimaging using MRI is considered the gold standard for detecting parenchymal inflammatory lesions, but is also not specific for cPACNS.  We hypothesize that patients can still be diagnosed with cPACNS even if they have normal initial MRI studies, hence consideration of brain biopsy is vital.  The aims of our study are:  (1)  To determine the proportion of children with confirmed cPACNS with normal initial MRI studies, and secondly, to calculate MRI sensitivity; (2)  To report their presenting clinical, laboratory and brain histopathology findings, treatment response and long-term outcome.

Methods:

We conducted a single centre cohort study of children diagnosed with cPACNS satisfying modified Calabrese criteria between 1990 and 2010.  The study included all patients with normal MRI studies (defined as no evidence of an inflammatory or ischemic lesion at diagnosis) with subsequent confirmatory brain biopsy.  Clinical, laboratory, histopathologic, treatment and patient outcome data was collected for these patients.  MRI-studies were evaluated by a neuroradiologist, and histopathology by a neuropathologist. 

Results:

Out of 107 children diagnosed with cPACNS, 80 children were diagnosed with angiography-positive cPACNS; all had abnormal MRIs.  27 patients were diagnosed with angiography-negative cPACNS; 25 (93%) had abnormal MRIs.  MRI sensitivity for the overall cohort was 98%, 100% for angiography-positive and 93% for angiography-negative cPACNS.  Two children fulfilled inclusion criteria:  previously healthy 11 and 13 year old males, both presenting with acute onset seizures progressing to refractory status epilepticus.  Both patients had elevated serum inflammatory markers.  One had a slightly raised WBC in CSF, the other had two normal CSF studies.  Both patients had extensive workup for infection and rheumatologic disease, returning negative.  Extensive imaging including CT, conventional angiogram, MRA, MRI, and MR spectroscopy returned normal.  Treatment was with a standardized protocol of small vessel cPACNS, including corticosteroids, pulse IV cyclophosphamide for 6 months, followed by maintenance Mycophenolate Mofetil for 18 months.  On last follow-up, one patient had mild residual neurologic deficits and intermittent seizures on anti-epileptics; the second had an excellent outcome with no neurologic deficit and seizure-free on Topiramate monotherapy. 

Conclusion:

Neuroimaging is a corner stone in the diagnostic evaluation of childhood CNS vasculitis.  In our cohort, MRI was highly sensitive, however, a negative MRI does not rule out the diagnosis of cPACNS.  In children presenting with refractory seizures, and/or if there is a high clinical suspicion, a brain biopsy should be considered despite repeatedly negative or non-diagnostic MRI studies.


Disclosure:

S. J. Lee,
None;

C. Hawkins,
None;

S. Laughlin,
None;

S. Sheikh,
None;

S. M. Benseler,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/brain-biopsy-diagnosis-in-magnetic-resonance-imaging-negative-childhood-primary-angiitis-of-the-central-nervous-system/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology